Patterson-UTI (PTEN) reported $1.18 billion in revenue for the quarter ended September 2025, representing a year-over-year decline of 13.4%. EPS of -$0.06 for the same period compares to $0 a year ago.
The reported revenue represents a surprise of +0.47% over the Zacks Consensus Estimate of $1.17 billion. With the consensus EPS estimate being -$0.10, the EPS surprise was +40%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Patterson-UTI performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:View all Key Company Metrics for Patterson-UTI here>>>
Shares of Patterson-UTI have returned +20.9% over the past month versus the Zacks S&P 500 composite's +3.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| Aug-14 | |
| Aug-12 | |
| Jul-30 | |
| Jul-30 | |
| Jul-29 | |
| Jul-29 | |
| Jul-14 | |
| Jul-09 | |
| Jul-06 | |
| Jun-05 | |
| May-07 | |
| May-06 | |
| Apr-24 | |
| Apr-23 | |
| Apr-22 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite